BC Extra | Oct 2, 2019
Financial News

Elicio to advance pancreatic, HPV vaccines, CAR T booster with $33M B round

Six months after raising a $30 million series A round, Elicio has added $33 million via its B round to begin Phase I/II testing of its KRAS-driven cancer vaccine ELI-002 and advance its other immunotherapies....
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

It is clear that Europe has hotspots of innovation that are discovering and developing the next wave of new therapeutic modalities. Nearly every category of new modality has a European champion, with clusters forming around...
BC Week In Review | Feb 15, 2019
Financial News

Anchiano prices $30.5M NASDAQ offering

Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) raised $30.5 million via a listing of ADSs on NASDAQ. On Feb. 12, the gene therapy company priced 2.6 million ADSs at $11.50, giving it a valuation of $78.5...
BC Extra | Feb 12, 2019
Financial News

Anchiano slips after NASDAQ offering

Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) slipped $0.70 to $10.80 on NASDAQ on Tuesday after raising $30.5 million in a listing of ADSs. The gene therapy company priced 2.6 million ADSs at $11.50, giving it...
BC Week In Review | Jan 11, 2019
Financial News

Alector, Poseida and Anchiano propose NASDAQ listings

Alector Inc. (South San Francisco, Calif.), Poseida Therapeutics Inc. (San Diego, Calif.) and Anchiano Therapeutics Inc. (Tel Aviv:ANCN) have proposed to list on NASDAQ. Alector, which aims to target immune dysfunction to treat neurodegenerative disorders,...
BC Extra | Jan 8, 2019
Financial News

Alector, Poseida and Anchiano propose NASDAQ listings

Alector Inc. (South San Francisco, Calif.), Poseida Therapeutics Inc. (San Diego, Calif.) and Anchiano Therapeutics Inc. (Tel Aviv:ANCN) have proposed to list on NASDAQ. Alector, which aims to target immune dysfunction to treat neurodegenerative disorders,...
BC Week In Review | Nov 16, 2018
Financial News

Neurology company Cadent emerges with $40M series B

Cadent Therapeutics Inc. (Cambridge, Mass.) emerged from stealth with news of a $40 million tranched series B round to bring its lead compound through Phase II trials to treat essential tremor and spinocerebellar ataxia (SCA)....
BC Extra | Nov 15, 2018
Financial News

Neurology company Cadent emerges with $40M series B

Cadent Therapeutics Inc. (Cambridge, Mass.) emerged from stealth with news of a $40 million tranched series B round to bring its lead compound through Phase II trials to treat essential tremor and spinocerebellar ataxia (SCA)....
BC Week In Review | Oct 5, 2018
Financial News

MeMed raises over $70M

MeMed Diagnostics Ltd. (Tirat Carmel, Israel) raised over $70 million on Sept. 20 in a financing. Participating in the round were Ping An Global Voyager Fund, Foxconn, Caesarea Medical Holdings, Clal Insurance, Phoenix Insurance, OurCrowd,...
BioCentury | May 18, 2018
Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
Items per page:
1 - 10 of 91
BC Extra | Oct 2, 2019
Financial News

Elicio to advance pancreatic, HPV vaccines, CAR T booster with $33M B round

Six months after raising a $30 million series A round, Elicio has added $33 million via its B round to begin Phase I/II testing of its KRAS-driven cancer vaccine ELI-002 and advance its other immunotherapies....
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

It is clear that Europe has hotspots of innovation that are discovering and developing the next wave of new therapeutic modalities. Nearly every category of new modality has a European champion, with clusters forming around...
BC Week In Review | Feb 15, 2019
Financial News

Anchiano prices $30.5M NASDAQ offering

Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) raised $30.5 million via a listing of ADSs on NASDAQ. On Feb. 12, the gene therapy company priced 2.6 million ADSs at $11.50, giving it a valuation of $78.5...
BC Extra | Feb 12, 2019
Financial News

Anchiano slips after NASDAQ offering

Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) slipped $0.70 to $10.80 on NASDAQ on Tuesday after raising $30.5 million in a listing of ADSs. The gene therapy company priced 2.6 million ADSs at $11.50, giving it...
BC Week In Review | Jan 11, 2019
Financial News

Alector, Poseida and Anchiano propose NASDAQ listings

Alector Inc. (South San Francisco, Calif.), Poseida Therapeutics Inc. (San Diego, Calif.) and Anchiano Therapeutics Inc. (Tel Aviv:ANCN) have proposed to list on NASDAQ. Alector, which aims to target immune dysfunction to treat neurodegenerative disorders,...
BC Extra | Jan 8, 2019
Financial News

Alector, Poseida and Anchiano propose NASDAQ listings

Alector Inc. (South San Francisco, Calif.), Poseida Therapeutics Inc. (San Diego, Calif.) and Anchiano Therapeutics Inc. (Tel Aviv:ANCN) have proposed to list on NASDAQ. Alector, which aims to target immune dysfunction to treat neurodegenerative disorders,...
BC Week In Review | Nov 16, 2018
Financial News

Neurology company Cadent emerges with $40M series B

Cadent Therapeutics Inc. (Cambridge, Mass.) emerged from stealth with news of a $40 million tranched series B round to bring its lead compound through Phase II trials to treat essential tremor and spinocerebellar ataxia (SCA)....
BC Extra | Nov 15, 2018
Financial News

Neurology company Cadent emerges with $40M series B

Cadent Therapeutics Inc. (Cambridge, Mass.) emerged from stealth with news of a $40 million tranched series B round to bring its lead compound through Phase II trials to treat essential tremor and spinocerebellar ataxia (SCA)....
BC Week In Review | Oct 5, 2018
Financial News

MeMed raises over $70M

MeMed Diagnostics Ltd. (Tirat Carmel, Israel) raised over $70 million on Sept. 20 in a financing. Participating in the round were Ping An Global Voyager Fund, Foxconn, Caesarea Medical Holdings, Clal Insurance, Phoenix Insurance, OurCrowd,...
BioCentury | May 18, 2018
Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
Items per page:
1 - 10 of 91